Does Ketamine Therapy Get You High

Ketamine Therapy: Understanding the Facts Behind the Treatment

Introduction

In recent years, ketamine therapy has emerged as a promising treatment option for individuals suffering from treatment-resistant depression, chronic pain, PTSD, and various anxiety disorders. As this treatment gains popularity in medical settings across the country, misconceptions and questions naturally arise. One of the most common questions potential patients ask is: “Does ketamine therapy get you high?” This concern is understandable, especially given ketamine’s history and portrayal in popular media.

Ketamine was first developed in the 1960s as an anesthetic agent and received FDA approval for anesthetic use in 1970. For decades, it has been listed by the World Health Organization as an “essential medicine” due to its safety profile and effectiveness. While ketamine has unfortunately gained notoriety for its misuse as a recreational drug, its therapeutic applications are fundamentally different in approach, dosage, setting, and purpose.

This article from The Recover aims to provide clear, evidence-based information about ketamine therapy, addressing common questions and misconceptions. We’ll explore how ketamine works in clinical settings, what patients can realistically expect, who might benefit from this treatment, and who should approach it with caution. Our goal is to separate medical facts from misinformation so that individuals and their healthcare providers can make informed decisions about whether ketamine therapy might be appropriate for their specific circumstances.

Important Disclaimer: This article is intended for educational purposes only and should not be considered medical advice. All medical decisions, including whether to pursue ketamine therapy, should be made in consultation with qualified healthcare professionals familiar with your specific medical history and needs.

Understanding Ketamine Therapy Basics

What Is Ketamine Therapy?

Ketamine therapy refers to the controlled, medical administration of ketamine for treating specific mental health conditions or chronic pain syndromes. Unlike traditional psychiatric medications that can take weeks to show effects, ketamine often produces rapid results, sometimes within hours or days of treatment.

In clinical settings, ketamine is primarily used for:

• Treatment-resistant depression
• Post-traumatic stress disorder (PTSD)
• Severe anxiety disorders
• Chronic pain conditions
• Suicidal ideation (often providing rapid relief)

Administration Methods

Ketamine therapy comes in several forms, each with different protocols and applications:

• Intravenous (IV) Infusion: The most common form for depression treatment, delivered slowly over 40-60 minutes in a controlled medical setting.
• Intranasal: The FDA-approved esketamine (Spravato), a nasal spray derived from ketamine, used for treatment-resistant depression.
• Intramuscular (IM) Injection: Less common but sometimes used when IV access is difficult or unavailable.
• Oral/Sublingual: Lower bioavailability but sometimes used for at-home maintenance between clinic treatments.

Does Ketamine Therapy Get You High?

This is perhaps the most common question about ketamine therapy, and the answer requires nuance. Ketamine therapy is not designed to produce a recreational “high,” but it does produce distinct alterations in consciousness that are considered therapeutically valuable.

During ketamine infusion, patients typically experience:

• A sense of dissociation (feeling detached from your body or surroundings)
• Changes in perception of time and space
• Heightened sensory experiences
• A shift in perspective or consciousness

These effects are fundamentally different from recreational use in several important ways:

1. Controlled Dosing: Medical ketamine uses precisely calculated doses based on weight and condition, typically much lower than recreational doses.
2. Medical Supervision: Treatment occurs under professional supervision with vital sign monitoring and psychological support.
3. Therapeutic Context: The clinical setting and therapeutic framework help direct the experience toward healing rather than recreation.
4. Integration Support: Medical protocols include preparation before and integration after treatment to process insights and maximize benefits.

Rather than seeking a “high,” ketamine therapy aims to leverage specific neurobiological effects to create lasting changes in brain function and thought patterns. The dissociative experience is often described by patients not as euphoric but as providing emotional distance from trauma or depression, allowing new perspectives on long-standing problems.

The Science Behind Ketamine’s Effects

Mechanism of Action

Ketamine works differently from traditional antidepressants like SSRIs or SNRIs. Its primary mechanisms include:

• NMDA Receptor Antagonism: Ketamine blocks N-methyl-D-aspartate receptors, which impacts glutamate signaling in the brain.
• Enhanced Neuroplasticity: Research suggests ketamine promotes the growth of new neural connections (synaptogenesis) and enhances brain plasticity.
• Anti-inflammatory Effects: Ketamine appears to reduce neuroinflammation, which is increasingly linked to depression and other mental health conditions.
• Default Mode Network Modulation: Similar to psychedelics, ketamine temporarily disrupts the brain’s default mode network, potentially allowing entrenched thought patterns to reset.

These mechanisms contribute to ketamine’s rapid-acting properties. While traditional antidepressants typically take weeks to show effects, ketamine can produce significant symptom relief within hours to days in responsive patients.

Is Ketamine a Psychedelic?

Technically, ketamine is classified as a dissociative anesthetic rather than a classic psychedelic. Classic psychedelics (like psilocybin, LSD, and DMT) primarily work through serotonin 5-HT2A receptor activation, while ketamine’s primary mechanism is NMDA receptor antagonism.

However, there are meaningful similarities and overlaps:

• Both can produce non-ordinary states of consciousness
• Both may create opportunities for psychological insights
• Both appear to disrupt rigid thought patterns associated with depression and anxiety
• Both may enhance neuroplasticity

Recent research suggests that while ketamine and classic psychedelics operate through different initial receptor targets, they may share downstream effects on brain networks and neuroplasticity. Some researchers now consider ketamine part of a broader category of “psychedelic-like” substances with therapeutic potential.

The differences are important for both scientific understanding and patient expectations. The ketamine experience is typically less visually oriented and more dissociative than classic psychedelic experiences, although individual responses vary considerably.

Safety Profile and Duration of Effects

How Long Does Ketamine Stay in Your System?

Ketamine has a relatively short half-life in the body:

• Blood/Plasma: Ketamine’s half-life in blood is approximately 2.5-3 hours
• Complete Elimination: Generally, ketamine and its metabolites are eliminated from the body within 24 hours
• Primary Metabolite: Norketamine (also active) typically clears the system within 24-48 hours
• Secondary Metabolites: Dehydronorketamine and hydroxynorketamine may be detectable slightly longer

Factors affecting elimination time include:

• Liver function (ketamine is metabolized primarily by the liver)
• Kidney function (metabolites are excreted through urine)
• Age (older adults may metabolize more slowly)
• Body composition
• Frequency of use (chronic use can slightly extend detection times)

Does Ketamine Show Up on a 12-Panel Drug Test?

Standard 12-panel drug tests typically do not screen for ketamine. These tests usually look for:

• Marijuana (THC)
• Cocaine
• Amphetamines/methamphetamines
• Opiates
• Benzodiazepines
• Barbiturates
• Methadone
• Oxycodone
• PCP
• Propoxyphene
• MDMA
• Buprenorphine

Ketamine requires specific testing to detect, and these specialized tests are not part of standard employment or probation screenings. However, it’s important to note:

1. If you’re receiving legitimate ketamine therapy, you can obtain documentation from your healthcare provider to explain any positive test results.
2. Some specialized or expanded panels might include ketamine, particularly in certain medical or forensic contexts.
3. If you have concerns about drug testing related to your ketamine treatment, discuss this with your healthcare provider and, if relevant, your employer’s HR department or other testing authorities.

How Long Does Ketamine Pain Relief Last?

The duration of ketamine’s pain-relieving effects varies based on the condition being treated and individual factors:

For Acute Pain Relief:

• The immediate analgesic effects typically last 2-3 hours after a single treatment
• Reduced pain sensitivity may continue for 24-48 hours

For Chronic Pain Conditions:

• A series of infusions (typically 4-6) may provide relief lasting weeks to months
• Many pain clinics use an initial “loading” series followed by maintenance treatments
• Some patients report cumulative benefits with repeated treatments over time

Factors affecting duration include:

• The specific pain condition being treated
• Individual metabolism and neurochemistry
• Treatment protocol (dose, frequency, number of sessions)
• Complementary treatments being used alongside ketamine

Most pain management protocols using ketamine involve a series of treatments rather than a single session, as this appears to produce more durable results. The optimal interval between maintenance treatments varies by individual.

Safety Monitoring and Side Effects

During ketamine treatment, providers typically monitor:

• Blood pressure and heart rate (ketamine can temporarily increase both)
• Oxygen saturation
• Mental status and subjective experience
• Signs of adverse reactions

Common side effects during treatment include:

• Nausea (often preventable with anti-nausea medication)
• Dizziness
• Feeling of floating or dissociation
• Temporary increase in blood pressure
• Visual disturbances
• Confusion or disorientation during the infusion

Most side effects resolve quickly after the infusion ends. Serious adverse reactions are rare when ketamine is administered under proper medical supervision and with appropriate patient screening.

Therapeutic Efficacy and Onset

How Fast Does Ketamine Work for Anxiety?

Ketamine’s onset of action for anxiety is typically rapid compared to traditional anxiety medications:

• Some patients report acute anxiety relief during or immediately following the first infusion
• For most patients, significant anxiety reduction occurs within 24-72 hours of treatment
• The initial effects may be temporary, but repeated treatments often lead to more sustained benefits
• Many protocols involve a series of 4-6 initial treatments over 2-3 weeks

Research shows ketamine may be particularly effective for anxiety disorders with comorbid depression. A 2020 study in the Journal of Psychiatric Research found that a single ketamine infusion reduced anxiety symptoms by approximately 50% in patients with treatment-resistant generalized anxiety disorder, with effects lasting up to one week after a single treatment.

The rapid action of ketamine can be particularly valuable for patients experiencing acute anxiety crises or those who haven’t responded to traditional anti-anxiety medications, which often require weeks to take effect and may have significant side effects of their own.

Patient Experiences and Expectations

While clinical data is promising, individual responses to ketamine for anxiety vary considerably. Some patients describe immediate and dramatic relief, while others experience more gradual improvements or require multiple sessions before noticing benefits.

A realistic perspective includes understanding that:

1. Ketamine is not typically a stand-alone cure for anxiety disorders but rather part of a comprehensive treatment approach.
2. The psychological insights gained during ketamine sessions often benefit from integration through therapy or other reflective practices.
3. For many patients, ketamine serves as a “circuit breaker” that interrupts entrenched anxiety patterns, creating a window of opportunity for implementing other anxiety management techniques.

Patient Selection and Contraindications

Who Is Not a Good Candidate for Ketamine Therapy?

While ketamine therapy has shown promising results for many conditions, it isn’t appropriate for everyone. Contraindications and cautions include:

Medical Contraindications:

• Uncontrolled hypertension
• Untreated cardiovascular disease
• History of stroke
• Increased intracranial pressure
• Untreated thyroid disease
• Severe liver disease
• Active substance use disorders
• Pregnancy (due to limited safety data)

Psychiatric Considerations:

• Active psychosis or schizophrenia spectrum disorders
• Unstable bipolar disorder (though ketamine may benefit some stable bipolar depression patients)
• Recent manic episodes
• Certain personality disorders that might be destabilized by dissociative experiences

Medication Interactions:

• Certain stimulants
• Particular antihypertensive medications
• Some anticonvulsants that might reduce ketamine’s effectiveness
• Medications that share liver metabolism pathways

The screening process for ketamine therapy typically involves:

• Comprehensive medical history review
• Psychiatric evaluation
• Physical examination
• Baseline vital signs
• Review of current medications
• Discussion of treatment expectations and goals

This thorough evaluation is essential for both safety and efficacy. Patients with relative contraindications may sometimes still receive ketamine therapy but require closer monitoring or modified protocols.

Common Misconceptions Clarified

Is Ketamine a Horse Tranquilizer?

One of the most persistent misconceptions about ketamine is its characterization as a “horse tranquilizer.” While ketamine is indeed used in veterinary medicine for various animals including horses, this framing is misleading for several reasons:

1. Ketamine’s Primary Development: Ketamine was developed for and first used in humans, not animals. Its use in veterinary medicine came after its established human medical use.
2. FDA Approval History: Ketamine received FDA approval for human use in 1970 and has been used safely in human medicine for more than 50 years.
3. Global Medical Status: The World Health Organization lists ketamine as an “Essential Medicine” for human use, recognizing its importance in healthcare systems worldwide.
4. Widespread Human Medical Use: Ketamine is routinely used in emergency medicine, battlefield medicine, pediatric procedures, and in areas with limited medical resources specifically because of its safety profile in humans.

The characterization of ketamine as primarily a veterinary medicine likely stems from media coverage of ketamine abuse cases and efforts to sensationalize stories about recreational use. This framing unfortunately stigmatizes a legitimate medicine and may discourage patients from considering a potentially beneficial treatment.

Other Common Misconceptions

Misconception: Ketamine therapy is the same as recreational ketamine use. Reality: Medical ketamine involves carefully controlled dosing, professional monitoring, therapeutic context, and integration support – all absent in recreational use.

Misconception: Ketamine therapy leads to addiction. Reality: When used in medical settings with appropriate screening and protocols, the risk of addiction from ketamine therapy is extremely low. Treatment frequency is carefully controlled to prevent tolerance or dependence.

Misconception: Ketamine therapy provides only temporary symptom relief. Reality: While some patients require ongoing maintenance treatments, others experience durable improvements after a single series of infusions, particularly when combined with appropriate therapy and lifestyle changes.

Misconception: Ketamine therapy is experimental and unproven. Reality: While research is ongoing, numerous peer-reviewed studies support ketamine’s efficacy for treatment-resistant depression, and the FDA has approved esketamine (Spravato) for this indication.

Practical Considerations for Patients

Is Ketamine Infusion Covered by Insurance?

The insurance landscape for ketamine therapy is evolving but remains complex:

• IV Ketamine Infusions: Most commercial insurance companies do not yet cover ketamine infusions for psychiatric conditions, though coverage for pain management may be available in some cases.
• Esketamine (Spravato): Being FDA-approved specifically for treatment-resistant depression, Spravato has better insurance coverage. Many major insurers now cover this treatment for qualifying patients, though prior authorization is typically required.
• Medicare/Medicaid: Some Medicare plans cover Spravato for treatment-resistant depression. Coverage for IV ketamine varies significantly by state and specific plan.
• Cost Considerations: Without insurance, ketamine infusions typically cost between $400-800 per session, with most initial treatment protocols requiring 4-6 sessions.

Many ketamine clinics offer payment plans or package pricing for the initial series of treatments. Some providers also work with patient assistance programs for those who qualify.

When evaluating insurance options:

1. Contact your insurance provider directly to inquire about coverage specifics
2. Ask if your plan covers “procedure code G2082 or G2083” (for Spravato) or CPT codes related to ketamine infusion
3. Determine if your provider will help with insurance prior authorization process
4. Consider whether out-of-network benefits might apply

Finding Qualified Providers

When seeking ketamine treatment, consider these factors when evaluating providers:

• Medical Credentials: Look for providers with board certification in psychiatry, anesthesiology, or pain medicine.
• Specific Ketamine Training: Ask about specialized training in ketamine administration and protocol development.
• Treatment Setting: Ensure treatments are conducted in appropriate medical facilities with emergency equipment available.
• Comprehensive Approach: The best providers incorporate preparation and integration support rather than simply administering the medication.
• Screening Process: A thorough evaluation before treatment suggests attention to safety and appropriate patient selection.
• Outcome Tracking: Quality providers systematically track patient outcomes using validated measurement tools.

Questions to ask potential providers include:

• What is your experience with ketamine therapy?
• How do you determine appropriate candidates?
• What monitoring occurs during treatment?
• What support is provided between treatments?
• What is your protocol for managing adverse reactions?
• How do you determine when to stop or continue treatments?

Is Ketamine Therapy Right For You?

Ketamine therapy represents one of the most significant recent advances in the treatment of certain mental health conditions and chronic pain syndromes. When properly administered in appropriate medical settings to carefully selected patients, it offers hope to many who haven’t responded to conventional treatments. Search ” Ketamine treatment near me” or contact our helpline and asked to be connected.